i
COVID-19 state of vaccine confidence insights report ; report 3 ,March 15, 2021
-
March 15, 2021
-
[PDF-1.72 MB]
Details:
-
Corporate Authors:
-
Description:Date Range: February 16, 2021 – March 1, 2021
Findings. Since the introduction of a third authorized COVID-19 vaccine in the United States, many people feel optimistic that a return to normal life is within reach. However, people’s concerns about the effectiveness of Johnson & Johnson’s Janssen COVID-19 Vaccine raise new threats to vaccine confidence. Consumers are afraid that the J&J/Janssen COVID-19 vaccine is an inferior product and that it will be distributed to racial and ethnic minority groups, and people with lower incomes, underscoring the need for trusted messengers to amplify messages about the effectiveness of all three vaccines. The percentage of adults wanting to “wait and see” before getting vaccinated continues to decrease, but those who remain in this category are more likely to be from communities of color and younger adults. They are also less likely to know someone who has already been vaccinated. Those who are already vaccinated and those who are considering vaccination are confused about safety guidelines for life after vaccination. They are primarily concerned about whether those who are vaccinated can spread the virus that causes COVID-19 through asymptomatic transmission, if quarantine guidelines from states still SoVC-report-3-508.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
